Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...
2 天
MyChesCo on MSNUC Davis Study Validates Rumin8’s Methane Reduction TechnologyThe first peer-reviewed scientific paper examining Rumin8’s investigational veterinary product has confirmed its ...
Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...
This trial will evaluate the feasibility of the company’s investigational AeroNova ® System in patients suffering from moderate to severe Acute Hypoxemic Respiratory Failure (AHRF). The ...
Lungpacer Medical, a leading neurostimulation company committed to advancing therapies that assist patients in overcoming the ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果